Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Archana De"'
Autor:
Debasmita Dutta, Priyanka Ray, Archana De, Arnab Ghosh, Raj Shankar Hazra, Pratyusha Ghosh, Snigdha Banerjee, Francisco J Diaz, Sunil P Upadhyay, Mohiuddin Quadir, Sushanta K Banerjee
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0297749 (2024)
Therapeutic options for managing Pancreatic ductal adenocarcinoma (PDAC), one of the deadliest types of aggressive malignancies, are limited and disappointing. Therefore, despite suboptimal clinical effects, gemcitabine (GEM) remains the first-line c
Externí odkaz:
https://doaj.org/article/1bc26728355241b6884996e7ea571b2f
Autor:
Amlan Das, Inamul Haque, Priyanka Ray, Arnab Ghosh, Debasmita Dutta, Mohiuddin Quadir, Archana De, Sumedha Gunewardena, Indranil Chatterjee, Snigdha Banerjee, Scott Weir, Sushanta K. Banerjee
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 2, Pp n/a-n/a (2021)
Abstract Epigallocatechin‐3‐gallate (EGCG) has been considered an anticancer agent despite conflicting and discrepant bioavailability views. EGCG impairs the viability and self‐renewal capacity of triple‐negative breast cancer (TNBC) cells an
Externí odkaz:
https://doaj.org/article/b505c43912fd405c8183a30ed25d5e1c
Autor:
Alok De, Archana De, Chris Papasian, Shane Hentges, Snigdha Banerjee, Inamul Haque, Sushanta K Banerjee
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e72748 (2013)
Patients with ovarian cancer (OC) may be treated with surgery, chemotherapy and/or radiation therapy, although none of these strategies are very effective. Several plant-based natural products/dietary supplements, including extracts from Emblicaoffic
Externí odkaz:
https://doaj.org/article/c4cc4756af614fa8a457aeb33e4e9dbc
Autor:
Debasmita Dutta, Archana De, Arnab Ghosh, Raj Shankar Hazra, Pratyusha Ghosh, Snigdha Banerjee, Francisco J. Diaz, Sunil P. Upadhyay, Mohiuddin Quadir, Sushanta K Banerjee
Therapeutic options for managing Pancreatic ductal adenocarcinoma (PDAC), one of the deadliest types of aggressive malignancies, are limited and disappointing. Therefore, despite suboptimal clinical effects, Gemcitabine (GEM) remains the first-line c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed7274ab32378eaaf70f59d53704f276
https://doi.org/10.21203/rs.3.rs-2909446/v1
https://doi.org/10.21203/rs.3.rs-2909446/v1
Autor:
Debasmita Dutta, Archana De, Raj Shankar Hazra, Pratyusha Ghosh, Mohiuddin Quadir, Snigdha Banerjee, Sushanta K. Banerjee
Publikováno v:
Cancer Research. 83:2701-2701
Therapeutic strategies for Pancreatic ductal adenocarcinoma (PDAC), one of the deadliest types of aggressive malignancies, remain challenging with poor prognosis, high mutational rate, and lowest patient survival among other cancers. The treatment op
Autor:
Natasha E Schoeler, Louise Marston, Laura Lyons, Sally Halsall, Ruchika Jain, Siobhan Titre-Johnson, Maryam Balogun, Simon J R Heales, Simon Eaton, Michael Orford, Elizabeth Neal, Christin Eltze, Elma Stephen, Andrew A Mallick, Finbar O’Callaghan, Shakti Agrawal, Alasdair Parker, Martin Kirkpatrick, Andreas Brunklaus, Ailsa McLellan, Helen McCullagh, Rajib Samanta, Rachel Kneen, Hui Jeen Tan, Anita Devlin, Manish Prasad, Rohini Rattihalli, Helen Basu, Archana Desurkar, Ruth Williams, Penny Fallon, Irwin Nazareth, Nicholas Freemantle, J Helen Cross
Publikováno v:
Efficacy and Mechanism Evaluation, Vol 11, Iss 16 (2024)
Background Many infancy-onset epilepsies have a poor prognosis for seizure control and neurodevelopmental outcome. Ketogenic diets can improve seizures in older children and adults unresponsive to antiseizure medicines. We aimed to determine the effe
Externí odkaz:
https://doaj.org/article/3cbdf6bf151e43c59877574331e8adad
Autor:
Amlan Das, Inamul Haque, Priyanka Ray, Arnab Ghosh, Debasmita Dutta, Mohiuddin Quadir, Archana De, Sumedha Gunewardena, Indranil Chatterjee, Snigdha Banerjee, Scott Weir, Sushanta Banerjee
Background and Purpose: Epigallocatechin-3-gallate (EGCG) has been considered an anticancer agent despite conflicting and discrepant bioavailability views. EGCG impairs the viability and self-renewal capacity of triple-negative breast cancer (TNBC) c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e40c1370056044181a926e97c1cce8b
https://doi.org/10.22541/au.164864795.55156696/v1
https://doi.org/10.22541/au.164864795.55156696/v1
Autor:
Sushanta K. Banerjee, Mohiuddin A. Quadir, Archana De, Indranil Chatterjee, Scott Weir, Snigdha Banerjee, Debasmita Dutta, Arnab Ghosh, Sumedha Gunewardena, Amlan Das, Priyanka Ray, Inamul Haque
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 2, Pp n/a-n/a (2021)
Pharmacology Research & Perspectives
Pharmacology Research & Perspectives
Epigallocatechin‐3‐gallate (EGCG) has been considered an anticancer agent despite conflicting and discrepant bioavailability views. EGCG impairs the viability and self‐renewal capacity of triple‐negative breast cancer (TNBC) cells and makes t
Publikováno v:
Journal of Cancer
Background: Ovarian cancer (OC), the most lethal gynecologic malignancy, is highly resistant to current treatment strategies. High-grade serous epithelial ovarian cancer (HGSOC) cells with increased somatic mutations and genomic instability and the r
Publikováno v:
Laboratory Investigation. 95:702-717
Acetylsalicylic acid (ASA), also known as aspirin, a classic, nonsteroidal, anti-inflammatory drug (NSAID), is widely used to relieve minor aches and pains and to reduce fever. Epidemiological studies and other experimental studies suggest that ASA u